Clinical trial reportCancerPublished
Talquetamab improves patient-reported symptoms and health-related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL-1 study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Antibodies, Bispecific; Quality of Life; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Patient Reported Outcome Measures
- PubMed ID
- 40631904
- PubMed Central ID
- PMC12239699
- Open access
- Yes, open
- Added to directory
- Source checked